Alkem Laboratories PAT at Rs 468.12 crore for Q1FY22
News

Alkem Laboratories PAT at Rs 468.12 crore for Q1FY22

EPS stood at Rs 39.15

  • By IPP Bureau | August 08, 2021

The company has reported a total income of Rs.2778.01 crores during the period ended June 30, 2021, as compared to Rs.2238.44 crores during the period ended March 31, 2021. The company had reported a total income of Rs 2046.99 crore for the quarter ended June 30, 2020.

The company has posted net profit / (loss) of Rs.468.12 crores for the period ended June 30, 2021, as against net profit / (loss) of Rs.239.99 crores for the period ended March 31, 2021.  The company had posted a net profit/(loss) of Rs 422.01 crores for the quarter ended June 30, 2020.

The company has reported EPS of Rs.39.15 for the period ended June 30, 2021, as compared to Rs.20.07 for the period ended March 31, 2021. The EPS for the quarter ended June 30, 2020, was Rs 35.30 crore. 

Other Related stories

Startup

Digitization

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International